OBJECTIVE: It has been reported that the levels of procoagulant microparticles (MPs) are increased in patients with acute coronary syndromes and this may contribute to the formation of intracoronary thrombi. In the current study, we investigated the presence of locally elevated MPs within the culprit coronary arteries of patients with ST-segment elevation myocardial infarction (STEMI). METHODS: The study population consisted of 45 patients with STEMI who underwent primary percutaneous coronary intervention (PCI), and 16 control patients. Before and after PCI, blood samples were collected from the femoral artery and from the culprit coronary arteries. In controls, only peripheral blood was obtained. MPs were measured by a solid-phase capture assay using a commercial kit. The cell origins of MPs were determined by antigenic capture with specific antibodies. RESULTS: Baseline levels of MPs in patients with STEMI were higher than in controls. Before PCI, the levels of MPs were significantly higher in culprit coronary arteries than in peripheral arteries in STEMI patients (20.7 ± 15.5 vs. 14.6 ± 15.4 nM phosphatidylserine (PS) equivalent, p = 0.027). MPs from the culprit coronary artery were significantly reduced after PCI (20.7 ± 15.5 vs. 14.3 ± 14.9 nM PS equivalent, p = 0.010). Similarly, the locally increased levels of endothelial- and platelet-derived MPs within the culprit coronary arteries were significantly decreased after PCI. CONCLUSION: Locally increased levels of MPs in culprit coronary arteries and their significant reduction after successful PCI suggest a potential role in coronary atherothrombosis in the early period of STEMI.
OBJECTIVE: It has been reported that the levels of procoagulant microparticles (MPs) are increased in patients with acute coronary syndromes and this may contribute to the formation of intracoronary thrombi. In the current study, we investigated the presence of locally elevated MPs within the culprit coronary arteries of patients with ST-segment elevation myocardial infarction (STEMI). METHODS: The study population consisted of 45 patients with STEMI who underwent primary percutaneous coronary intervention (PCI), and 16 control patients. Before and after PCI, blood samples were collected from the femoral artery and from the culprit coronary arteries. In controls, only peripheral blood was obtained. MPs were measured by a solid-phase capture assay using a commercial kit. The cell origins of MPs were determined by antigenic capture with specific antibodies. RESULTS: Baseline levels of MPs in patients with STEMI were higher than in controls. Before PCI, the levels of MPs were significantly higher in culprit coronary arteries than in peripheral arteries in STEMI patients (20.7 ± 15.5 vs. 14.6 ± 15.4 nM phosphatidylserine (PS) equivalent, p = 0.027). MPs from the culprit coronary artery were significantly reduced after PCI (20.7 ± 15.5 vs. 14.3 ± 14.9 nM PS equivalent, p = 0.010). Similarly, the locally increased levels of endothelial- and platelet-derived MPs within the culprit coronary arteries were significantly decreased after PCI. CONCLUSION: Locally increased levels of MPs in culprit coronary arteries and their significant reduction after successful PCI suggest a potential role in coronary atherothrombosis in the early period of STEMI.
Authors: Murad Vagida; Anush Arakelyan; Anna Lebedeva; Jean-Charles Grivel; Alexander Shpektor; Elena Vasilieva; Leonid Margolis Journal: Platelets Date: 2016-09-05 Impact factor: 3.862
Authors: M S Vagida; A Arakelyan; A M Lebedeva; J-Ch Grivel; A V Shpektor; E Yu Vasilieva; L B Margolis Journal: Biochemistry (Mosc) Date: 2016-04 Impact factor: 2.487
Authors: Christopher E Radecke; Alexandra E Warrick; Gagan D Singh; Jason H Rogers; Scott I Simon; Ehrin J Armstrong Journal: Thromb Haemost Date: 2014-11-20 Impact factor: 5.249
Authors: Dimitrios Tsiantoulas; Thomas Perkmann; Taras Afonyushkin; Andreas Mangold; Thomas A Prohaska; Nikolina Papac-Milicevic; Vincent Millischer; Caroline Bartel; Sohvi Hörkkö; Chantal M Boulanger; Sotirios Tsimikas; Michael B Fischer; Joseph L Witztum; Irene M Lang; Christoph J Binder Journal: J Lipid Res Date: 2014-12-18 Impact factor: 5.922
Authors: E Gkaliagkousi; E Gavriilaki; E Yiannaki; I Vasileiadis; B Nikolaidou; A Lazaridis; P Dolgyras; S Grigoriadis; A Triantafyllou; P Anyfanti; D Markala; I Zarifis; S Douma Journal: J Thromb Thrombolysis Date: 2020-10-11 Impact factor: 2.300
Authors: Patrick Horn; Theodor Baars; Philipp Kahlert; Christian Heiss; Ralf Westenfeld; Malte Kelm; Raimund Erbel; Gerd Heusch; Petra Kleinbongard Journal: PLoS One Date: 2015-04-27 Impact factor: 3.240
Authors: Theoni Kanellopoulou; Alexandra Alexopoulou; Flora N Kontopidou; Polydoros Konstantinides; George V Papatheodoridis Journal: Ann Gastroenterol Date: 2016 Apr-Jun